Position in PHAR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$191,176
+$55,117 QoQ
Shares Held
11,489
+49.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in PHAR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. PHAR ranks #331 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in PHAR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $191,176 | 11,489 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $136,059 | 7,700 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $63,147 | 4,355 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $31,001 | 2,900 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $24,261 | 2,900 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $26,168 | 2,600 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $27,225 | 3,300 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $23,380 | 2,800 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $30,352 | 2,800 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $32,004 | 2,800 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $28,500 | 2,500 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $29,125 | 2,500 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $33,750 | 2,500 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $73,338 | 6,649 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $66,420 | 6,750 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,900 | 2,500 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $22,475 | 2,500 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $22,350 | 2,500 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $24,206 | 2,548 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $28,715 | 2,548 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $615 | 48 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||